Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer. - Wikidata - wikimedia - TriplyDB

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer.

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer.

http://www.wikidata.org/entity/Q37043425

about

Evidence-based approaches to reduce cancer health disparities: Discover, develop, deliver, and disseminate.Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Guidelines

P2860

Q55013480-F5099455-8540-4DE1-AA1F-2FB2D7C3BFBC Q57150651-DF667B45-9CB9-4CE3-9465-3E9169CB5C97

P2860

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer.

http://www.wikidata.org/entity/Q37043425

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@en

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@nl

type

label

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@en

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@nl

prefLabel

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@en

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@nl

P1433

Q37043425-B7A6A754-0FE1-4143-BBD2-163745C14E0A

P1476

Q37043425-7AF1E636-F553-4B10-8A09-004C028F8CB6

P2093

Q37043425-1924A472-1178-4305-BF80-02343981D19B

Q37043425-1EDEE275-A76F-4FF0-BEBA-B5285EB90BB7

Q37043425-66BEE8A2-50A1-4D96-9C53-C9F6F895584A

Q37043425-88004489-E599-46C3-8FED-836D842062B4

Q37043425-A57008DB-D3C2-4800-99D3-EEFB7114802F

Q37043425-D9DAB549-CAF5-4250-B190-A6E8B06FC5E5

Q37043425-E743E356-6194-4FA4-B657-10D0D7CF07A9

P2860

Q37043425-0A29A956-B28B-4666-B6D6-CB6851D712DD

Q37043425-0DFB244F-3E7B-4F8F-B7C3-66643124FC79

Q37043425-1130D9DF-3106-4CB7-B86B-78FC1B19C7A1

Q37043425-20323012-8721-4495-8DE9-29FEC96DDA95

Q37043425-223263B8-35CF-497C-8526-32302B3D7DDD

Q37043425-2321C521-3B7C-42C8-A468-C42037CFFA21

Q37043425-2B084288-F028-42E1-9520-54D83C1BDDD0

Q37043425-2F2F0B0C-A0BC-4DC6-B8D7-B4FA814FDC30

Q37043425-4E449EAF-B65E-480E-8E55-8730EBA1DC0F

Q37043425-5B9D95DA-FF1F-477A-8C7E-9EFF123A9200

P304

Q37043425-3C153858-BE3F-468B-98A9-EE53F87A226B

P31

Q37043425-27C814DC-102B-4E94-BD27-03F8D271A3A5

P356

Q37043425-3271069C-AE7D-4091-AFF4-650A833BCA45

P478

Q37043425-06AC67F6-042C-434E-B1ED-BD38515F2E02

P50

Q37043425-6BF1E148-DCBC-4A99-AF0F-883A450DAEFB

Q37043425-a4a49ee9-455e-0e08-d536-3353270bc064

P577

Q37043425-FD1B9FA6-0E89-491B-8B79-DD0B3507172A

P698

Q37043425-90C9956F-B579-493F-BE66-1E81648DBD4A

P932

Q37043425-8ADBF89D-4566-43D0-A020-0292B942838D

P356

FONC.2016.00157

P1433

Frontiers in Oncology

P1476

Age and Prostate-Specific Anti ...... of Death from Prostate Cancer.

@en

P2093

Cayce B Nawaf

http://www.w3.org/2001/XMLSchema#string

Christopher H Morrell

http://www.w3.org/2001/XMLSchema#string

Lori Rawson

http://www.w3.org/2001/XMLSchema#string

Louise C Walter

http://www.w3.org/2001/XMLSchema#string

Preston C Sprenkle

http://www.w3.org/2001/XMLSchema#string

R Jeffrey Karnes

http://www.w3.org/2001/XMLSchema#string

Thomas B Neville

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Screening and prostate-cancer mortality in a randomized European study

Multiple Comparisons among Means

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.

P304

157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2016.00157

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Michael W Kattan

Frederick Roy MacKintosh

P577

2016-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27446803

http://www.w3.org/2001/XMLSchema#string

P932

4923265

http://www.w3.org/2001/XMLSchema#string